Comparing mitral transcatheter edge-to-edge repair and surgical intervention in mitral regurgitation: A meta-analysis
Journal of Cardiovascular and Thoracic Research · 30.03.2026 · 18 (1) · 4-14
DOI: 10.34172/jcvtr.026.33487 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular and Thoracic Research, online erschienen am 30.03.2026. Verfasst von Emídio Mata und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Unidade Local de Saúde de Alto Ave, Guimarães, Portugal. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Surgery remains the standard treatment for severe mitral valve regurgitation (MR), but growing evidence highlights the potential role of mitral valve percutaneous edge-to-edge repair (M-TEER). This meta-analysis aims to compare 12-month all-cause mortality between M-TEER and surgical intervention (SMVI). A systematic search (October 2024) of PubMed, Cochrane, Scopus, and Web of Science identified randomized control trials (RCTs) and propensity-matched observational studies comparing 12-month all-cause mortality in MR patients treated with M-TEER or SMVI. An inverse variance random-effects meta-analysis assessed outcomes using risk ratios (RR) and 95% confidence intervals (CI). Two RCTs (MATTERHORN and EVEREST II) and three observational studies totaling 1,782 patients, were included in the final analysis. A non-significant trend of higher mortality at 30 days was observed in the SMVI group (RR: 0.72; CI: 0.26–2.00), along with higher complication rates mainly due to bleeding. At 12 months follow-up, SMVI was associated with a significantly lower risk of all-cause mortality (RR: 1.41; CI: 1.11–1.81), while the M-TEER group had more patients with MR grade 3 or higher (RR: 4.05; CI: 1.54–10.67), with a non-significant trend of higher rate of MR reintervention (RR 2.51; CI 0.83–7.66) at 12 months. Based on current evidence, M-TEER should continue to be reserved for patients with prohibitive high surgical risk. While propensity-matched cohorts were pooled for the study estimates, the limited available data from randomized trials, combined with heterogeneity in patient populations, particularly regarding MR etiology, underscores the need for further studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Department, Unidade Local de Saúde de Alto Ave, Guimarães, Portugal.
ORCID-Profile: Emídio Mata, Barbara Lage Garcia, Margarida Castro, Mariana Tinoco, Luísa Pinheiro, João Português, António Lourenço
Zitieren
APA
Mata, E., Lage Garcia, B., Castro, M., Tinoco, M., Pinheiro, L., Português, J., Ferreira, F., Calvo, L., Ribeiro, S., & Lourenço, A. (2026). Comparing mitral transcatheter edge-to-edge repair and surgical intervention in mitral regurgitation: A meta-analysis. Journal of Cardiovascular and Thoracic Research, 18(1), 4-14. https://doi.org/10.34172/jcvtr.026.33487
Vancouver
Mata E, Lage Garcia B, Castro M, Tinoco M, Pinheiro L, Português J, et al. Comparing mitral transcatheter edge-to-edge repair and surgical intervention in mitral regurgitation: A meta-analysis. Journal of Cardiovascular and Thoracic Research. 2026;18(1):4-14. doi:10.34172/jcvtr.026.33487
BibTeX
@article{Mata2026,
author = {Mata, Emídio and Lage Garcia, Barbara and Castro, Margarida and Tinoco, Mariana and Pinheiro, Luísa and Português, João and Ferreira, Francisco and Calvo, Lucy and Ribeiro, Sílvia and Lourenço, António},
title = {Comparing mitral transcatheter edge-to-edge repair and surgical intervention in mitral regurgitation: A meta-analysis},
journal = {Journal of Cardiovascular and Thoracic Research},
year = {2026},
volume = {18},
number = {1},
pages = {4--14},
doi = {10.34172/jcvtr.026.33487}
}
EUVIMED